CureVac NV (5CV) — Cash Flow-to-Debt Ratio
CureVac NV (5CV) has a Cash Flow-to-Debt Ratio of 0.11x as of September 2025, meaning its operating cash flow of €29.86 Million could theoretically repay 0% of its total liabilities (€267.39 Million) in one year. See CureVac NV leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
CureVac NV Cash Flow-to-Debt Ratio (2018–2024)
Historical debt coverage capacity for CureVac NV across 7 annual periods. For the full cash flow conversion analysis, see CureVac NV (5CV) cash flow conversion.
Annual Cash Flow-to-Debt Ratio for CureVac NV (2018–2024)
Year-by-year debt coverage analysis for CureVac NV. Check earnings quality score of CureVac NV to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.96x | €101.85 Million | €106.22 Million | ▲ +197.1% |
| 2023 | -0.99x | €-267.89 Million | €271.31 Million | ▼ -12.9% |
| 2022 | -0.87x | €-286.18 Million | €327.22 Million | ▲ +44.0% |
| 2021 | -1.56x | €-733.13 Million | €469.77 Million | ▼ -339.0% |
| 2020 | 0.65x | €522.40 Million | €800.01 Million | ▲ +230.2% |
| 2019 | -0.50x | €-86.96 Million | €173.42 Million | ▲ +36.7% |
| 2018 | -0.79x | €-74.11 Million | €93.58 Million | — |